About Vedea Parent App
EXCLUSIVELY FOR CLINICAL INVESTIGATION — not CE-marked
This product is an investigational medical device and does not yet have a CE mark. Use is only permitted within the approved clinical trial. Follow the instructions of your investigating clinician.
Device & Manufacturer Identification
Device trade nameVedea Amblyopia Therapy (VAT)UDI-DI (VAT Therapy App)8720938514005Investigational Version (Therapy / Game App)2.0Parent App release (PWA)Last Update 2026-04-01Clinical investigation referenceTrial 2 · NL-010980 / OZR-2024-13ManufacturerVedea Healthware B.V.AddressEuropalaan 400, 3526 KS Utrecht, The NetherlandsChamber of Commerce (KvK)76188345Phone+31 85 250 2515Emailinfo@vedea.comWebwww.vedea.comInstructions for Usewww.vedea.com/ifuUser supportsupport.vedea.com
About the Device
This Vedea Amblyopia Therapy (VAT) Research Version is a digital therapy for children with amblyopia (lazy eye). The therapy is delivered via a smartphone in a Google Cardboard compatible VR headset, in combination with this companion app for parents.
In this research phase, VAT is used to further substantiate effectiveness and safety. The therapy is always prescribed and supervised by an ophthalmologist or orthoptist.
What This App Does
View progress, contact the support team, access patient information (playtime monitoring), and access help documents.
Clinical Research
Research Protocol: NL-010980 · PI-01.01 / OZR-2024-13
METC: Medical Research Ethics Committee Erasmus MC
WMO Registration: WMO NL-010980
Research Site: The Rotterdam Eye Hospital (ROI)
Sponsor: Vedea Healthware B.V., Utrecht
The study is conducted in accordance with ICH-GCP, ISO 14155, and MDR 2017/745 Article 62.
For full participant information and the signed Informed Consent Form (ICF): see Documents in the menu of this app.
Reporting Serious Adverse Events
If anything occurs during or after a therapy session that concerns you, such as persistent headache, nausea, double vision, or any other unexpected event, please contact:
Email: support@vedea.com
Phone: +31 85 250 2515
Or via the treating ophthalmologist or orthoptist at The Rotterdam Eye Hospital
For questions or concerns outside of the research team, you may contact the independent physician listed in your Participant Information Sheet (PIS). You may also report incidents directly to the Dutch Health and Youth Care Inspectorate (IGJ) via www.igj.nl.
Help & Contact
Research Helpdesk for questions on use of the app or VR headset:
Email: support@vedea.com
Phone: +31 85 250 2515
Online: support.vedea.com
Opening hours: weekdays 09:00 to 17:00. We aim to respond immediately via live chat, or within 2 business days for non-urgent queries.
Privacy & Your Data
Vedea processes your child's personal data exclusively within the approved research protocol, in accordance with the General Data Protection Regulation (GDPR) and ICH-GCP. Data is stored on servers within the European Union.
Privacy inquiries: info@vedea.com. See our full Privacy Policy for Research Participants.
Participant Rights
As a participant, or as the legal representative of a participant, you have the right to:
Withdraw your consent at any time, without providing a reason
Access the data collected about your child
Request correction or deletion of data, insofar as research methodology permits
Ask questions to an independent physician not involved in the study
To exercise these rights, email info@vedea.com or contact the research team.
Technical Information
Parent Application: Progressive Web App. Release identifier: deployment timestamp (Last Update above) plus git commit SHA recorded under SOP-201
Therapy App (Game App): Android application, distributed via Google Play Store
UDI-DI Therapy App: 8720938514005
Supported OS (Therapy App): Android 13 or higher
Supported OS (Parent App): Android 13 or higher, or iOS 16 or higher
Hardware: Smartphone in a Google Cardboard compatible VR headset. Current compatibility list at support.vedea.com
Open Source & Licenses
This app uses open-source components. The full list of licenses and attributions: 3rd-party-licenses.
Documents
Participant Information Sheet (PIS)
Informed Consent Form (ICF)
Instructions for Use (IFU)
Privacy Policy for Research Participants
This product does not have a CE mark and is not commercially available. Use exclusively within the approved clinical trial.
About Vedea Parent App
EXCLUSIVELY FOR CLINICAL INVESTIGATION — not CE-marked
This product is an investigational medical device and does not yet have a CE mark. Use is only permitted within the approved clinical trial. Follow the instructions of your investigating clinician.
Device & Manufacturer Identification
Device trade name: Vedea Amblyopia Therapy (VAT)
UDI-DI (VAT Therapy App): 8720938514005
Investigational Version (Therapy / Game App): 2.0
Parent App release (PWA): Last Update 2026-06-06
Clinical investigation reference: Trial 2 · NL-010980 / OZR-2024-13
Manufacturer: Vedea Healthware B.V.
Address:Europalaan 400, 3526 KS Utrecht, The Netherlands
Chamber of Commerce (KvK): 76188345
Phone: +31 85 250 2515
Email: info@vedea.com
Web: www.vedea.com
Instructions for Use: www.vedea.com/ifu
User support: support.vedea.com
About the Device
This Vedea Amblyopia Therapy (VAT) Research Version is a digital therapy for children with amblyopia (lazy eye). The therapy is delivered via a smartphone in a Google Cardboard compatible VR headset, in combination with this companion app for parents.
In this research phase, VAT is used to further substantiate effectiveness and safety. The therapy is always prescribed and supervised by an ophthalmologist or orthoptist.
What This App Does
View progress, contact the support team, access patient information (playtime monitoring), and access help documents.
Clinical Research
Research Protocol: NL-010980 · PI-01.01 / OZR-2024-13
METC: Medical Research Ethics Committee Erasmus MC
WMO Registration: WMO NL-010980
Research Site: The Rotterdam Eye Hospital (ROI)
Sponsor: Vedea Healthware B.V., Utrecht
The study is conducted in accordance with ICH-GCP, ISO 14155, and MDR 2017/745 Article 62.
For full participant information and the signed Informed Consent Form (ICF): see Documents in the menu of this app.
Reporting Serious Adverse Events
If anything occurs during or after a therapy session that concerns you, such as persistent headache, nausea, double vision, or any other unexpected event, please contact:
Email: support@vedea.com
Phone: +31 85 250 2515
Or via the treating ophthalmologist or orthoptist at The Rotterdam Eye Hospital
For questions or concerns outside of the research team, you may contact the independent physician listed in your Participant Information Sheet (PIS). You may also report incidents directly to the Dutch Health and Youth Care Inspectorate (IGJ) via www.igj.nl.
Help & Contact
Research Helpdesk for questions on use of the app or VR headset:
Email: support@vedea.com
Phone: +31 85 250 2515
Online: support.vedea.com
Opening hours: weekdays 09:00 to 17:00. We aim to respond immediately via live chat, or within 2 business days for non-urgent queries.
Privacy & Your Data
Vedea processes your child's personal data exclusively within the approved research protocol, in accordance with the General Data Protection Regulation (GDPR) and ICH-GCP. Data is stored on servers within the European Union.
Privacy inquiries: info@vedea.com. See our full Privacy Policy for Research Participants.
Participant Rights
As a participant, or as the legal representative of a participant, you have the right to:
Withdraw your consent at any time, without providing a reason
Access the data collected about your child
Request correction or deletion of data, insofar as research methodology permits
Ask questions to an independent physician not involved in the study
To exercise these rights, email info@vedea.com or contact the research team.
Technical Information
Parent Application: Progressive Web App. Release identifier: deployment timestamp (Last Update above) plus git commit SHA recorded under SOP-201
Therapy App (Game App): Android application, distributed via Google Play Store
UDI-DI Therapy App: 8720938514005
Supported OS (Therapy App): Android 13 or higher
Supported OS (Parent App): Android 13 or higher, or iOS 16 or higher
Hardware: Smartphone in a Google Cardboard compatible VR headset. Current compatibility list at support.vedea.com
Open Source & Licenses
This app uses open-source components. The full list of licenses and attributions: 3rd-party-licenses.
Documents
Participant Information Sheet (PIS)
Informed Consent Form (ICF)
Instructions for Use (IFU)
Privacy Policy for Research Participants
This product does not have a CE mark and is not commercially available. Use exclusively within the approved clinical trial.
Vedea Healthware BV
Hekelsteeg 4
3511AK Utrecht
info@vedea.com
+31 85 250 2515
Go to
Vedea Healthware BV
Hekelsteeg 4
3511AK Utrecht
info@vedea.com
+31 85 250 2515
Go to
Vedea Healthware BV
Hekelsteeg 4
3511AK Utrecht
info@vedea.com
+31 85 250 2515


